A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer

Author： Yeo Chang   Lee Sang   Kim Ju   Kim Seung   Kim Seok   Kim Young   Kang Hyeon   Yoon Hyung   Song Jeong   Moon Hwa   Kim Jin   Kim Kwan   Shim Byoung   Kim Chi  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.4, 2013-10, pp. : 809-814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer

By Araujo Antonio   Mendez Jose   Coelho Ana   Sousa Berta   Barata Fernando   Figueiredo Ana   Amaro Teresina   Azevedo Isabel   Soares Marta  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer

By Fukuda Minoru   Oka Mikio   Soda Hiroshi   Kinoshita Akitoshi   Fukuda Masaaki   Nagashima Seiji   Kuba Mutsuo   Takatani Hiroshi   Tsurutani Junji   Nakamura Yoichi   Kasai Takashi   Inoue Yuichi   Soejima Yoshifumi   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

By Tomonaga Nanae   Nakamura Yoichi   Soda Hiroshi   Nagashima Seiji   Nakano Hirofumi   Kinoshita Akitoshi   Fukuda Masaaki   Fukuda Minoru   Takatani Hiroshi   Soejima Yoshifumi   Oka Mikio   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 43-49

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite